- Home
- CMPX vs NAN Comparison
CMPX vs NAN Comparison
Compare CMPX & NAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- NAN
- Stock Information
- Founded
- CMPX 2014
- NAN 1999
- Country
- CMPX United States
- NAN United States
- Employees
- CMPX N/A
- NAN N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- NAN Investment Managers
- Sector
- CMPX Health Care
- NAN Finance
- Exchange
- CMPX Nasdaq
- NAN Nasdaq
- Market Cap
- CMPX 291.8M
- NAN 349.4M
- IPO Year
- CMPX N/A
- NAN N/A
- Fundamental
- Price
- CMPX $3.20
- NAN $10.99
- Analyst Decision
- CMPX Strong Buy
- NAN
- Analyst Count
- CMPX 9
- NAN 0
- Target Price
- CMPX $12.67
- NAN N/A
- AVG Volume (30 Days)
- CMPX 729.4K
- NAN 74.6K
- Earning Date
- CMPX 08-11-2025
- NAN 01-01-0001
- Dividend Yield
- CMPX N/A
- NAN 4.37%
- EPS Growth
- CMPX N/A
- NAN N/A
- EPS
- CMPX N/A
- NAN N/A
- Revenue
- CMPX $850,000.00
- NAN N/A
- Revenue This Year
- CMPX N/A
- NAN N/A
- Revenue Next Year
- CMPX N/A
- NAN N/A
- P/E Ratio
- CMPX N/A
- NAN N/A
- Revenue Growth
- CMPX N/A
- NAN N/A
- 52 Week Low
- CMPX $0.87
- NAN $9.11
- 52 Week High
- CMPX $4.08
- NAN $11.34
- Technical
- Relative Strength Index (RSI)
- CMPX 64.53
- NAN 23.26
- Support Level
- CMPX $3.11
- NAN $11.15
- Resistance Level
- CMPX $3.45
- NAN $11.47
- Average True Range (ATR)
- CMPX 0.20
- NAN 0.08
- MACD
- CMPX 0.01
- NAN -0.04
- Stochastic Oscillator
- CMPX 69.33
- NAN 8.23
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.